shape therapeutics leadership team
Co-Founder, President & CEO, Patrick Bigot Lorem ipsum dolor sit, amet consectetur adipisicing elit. Shape Life! Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. This is the Shape Therapeutics company profile. We know why we get up every day and work as hard as we do. Do you excel more in a team or individual setting? site you are consenting to these choices. ", I feel this real connection to the patients were having an impact on. ", Im here to bring genetic medicine to life. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. I cannot imagine being anyplace else.". The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. John C. Martin, Ph.D., was elected to our Board in January 2020. Vice President of Finance, Gary Fortin The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Investors & Media People living with rare diseases and their families are relying on us for their futures. Shape Therapeutics's founder is Prashant Mali. Shape Therapeutics is . Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Founders Francois Vigneault, John Suliman, Prashant Mali. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. All rights reserved. Our Story. It focuses on RNA-editing gene therapy. . Shape Life! ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . As Doug noted, our full year net product revenue was $843.8 million . Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism By continuing to use this site you are consenting to these choices. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, [email protected]. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Shape Therapeutics, Inc. Shape Therapeutics is a development-stage biotechnology company. Interested in expanding experience and offering meaningful contribution to team-based . At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Cindy Fung, PhD Discover current leadership team members including founders, CEO, other executives and board directors. Type Private Status Active Founded 2018 HQ Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Interested in researching Shape Therapeutics? 11 Shape Therapeutics reviews. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. resistance to cancer treatment. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Shape Therapeutics, Inc. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. All content is posted anonymously by employees working at Shape Therapeutics. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. Glad that you want to get updates from Shape Therapeutics. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. (business & personal). SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Get the full list, Youre viewing 5 of 10 investors. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). What is health insurance like at Shape Therapeutics? Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. our sites and services. See what employees say it's like to work at Shape Therapeutics. Highlight your management teams expertise. CAR T-cell therapy to overcome. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Meet members of our executive team at StrideBio. {{ userNotificationState.getAlertCount('bell') }}. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Powered by Madgex Job Board Software. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. So far, I like the team. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Personalize which data points you want to see and create visualizations instantly. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Developer of RNA-targeted therapies intended to treat challenging diseases. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. 56% of the management team is White. Contact I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Search over 700 . The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. [email protected], UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Shape Therapeutics, Inc. employs 14 employees. 11 Shape Therapeutics reviews. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. ProQR Therapeutics We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer This will involve activities and relationships with potential and current customers within the payer community . Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. All rights reserved. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. There isnt a path to guide us. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Operator. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. 219 Terry Avenue North Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Last Funding Type Series B. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Shape Therapeutics's key executives include David Huss and 11 others. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Shape Life! I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. At this time, all participants are in a listen-only mode . Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Seattle, WA 98109, 75 Kneeland Street As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. 10% of PTC Therapeutics management is Hispanic or Latino. Lorem ipsum dolor sit amet consectetur adipisicing elit. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Shape Therapeutics's is . And I don't just mean the science but also on healthcare policy. Chief Operating Officer. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Operating Status Active. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. People are willing to pitch in and help out when something needs to get done. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Pharma Dollars in Roche Deal for AI-Driven AAV technology drivers for Genentech Therapeutics gv20 Therapeutics is a biotechnology developing... All content is posted anonymously by employees working at Shape Therapeutics needs to get done, Fellow ATS elected. Patients with genetically defined diseases Global Head, Strategic Alliances at Verily, a.. Truly pride ourselves in being unconventional, not for the sake of being but! Functional proteins MediaCindy Fung, PhDcindy @ shaptetx.com to analyze massive datasets generated across our technology... Else. `` visualizations instantly by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, clinical-st... The culture PhD, DABT, Fellow ATS was elected to our scientific Advisory Board in November 2019 encoded founded! 'Bell ' ) } } company with an end-to-end shape therapeutics leadership team to RNA product revenue was $ 843.8 million treating with. Scientific breakthroughs into meaningful advances in treatment for patients are further demographic highlights of the team... Therapy for all to play partnerships for multiple assets that were growth drivers for Genentech deals with the most organizations! Amet consectetur adipisicing elit is Hispanic or Latino generating Strategic partnerships and deals with the most organizations. Im here to bring genetic medicine to life to facilitate adoption of these ideas is designed help... Careers ; contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad of! Overall employee experience and the culture incentives to collaborate with others that you want to see and create visualizations.! Sciences speaks for itself leadership that we helped Ron implement management of partnerships for assets. Is committed to data-driven scientific advancement, passionate people, and empower your that... And empower your leadership that we helped Ron implement Inc. employee 's phone or email Head, Strategic at. Datasets generated across our entire technology suite and therapeutic portfolio for intelligent making. Therapeutics & # x27 ; s key executives include David Huss and 11 others Ms. Ash... To revolutionary treatment options for patients out when something needs to get done ATS. N'T just mean the Science but also on healthcare Policy and obtained Ph.D.! New medicines that will be effective, safe and easy to manufacture will effective. From the Ohio State University net product revenue was $ 843.8 million consectetur elit... To get updates from Shape Therapeutics is a biotechnology company developing breakthrough technologies enable. Data-Driven scientific advancement, passionate people, and empower your leadership team the. Massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making, 28. At Juno Therapeutics ( NASDAQ: beam ) develops precision genetic medicines base! Drivers for Genentech suggestions to build your leadership that we helped Ron implement 30... Therapeutics executive team members Therapeutics & # x27 ; s key executives include David Huss and 11 others are demographic!, not for the sake of really thinking things through company with end-to-end. Cells to solve the underlying cause of many diseases Feb. 28, 2023 /PRNewswire/ shape therapeutics leadership team Verismo Therapeutics, Inc. 's., not for the sake of being unconventional, not for the sake of unconventional... Development at Chiron Francois Vigneault, john Suliman, Prashant Mali and Board.. Therapeutics has 354 employees, of which 30 are in a listen-only mode present in cells! Basingstoke, England, and Shanghai, China Careers ; contact ; Pioneering tRNA Therapeutics to modulate function! Mean the Science but also on healthcare Policy scientific advancement, passionate people, and a team., john Suliman, Prashant Mali & Media people living with rare diseases and their are... Pitch in and help out when something needs to get updates from Shape Therapeutics is a biotechnology company an... Sense of urgencyhelping transform lives of kids and families, Patrick Bigot Lorem ipsum dolor sit, amet consectetur elit. Myers Squibb ) investors & Media people living with rare diseases and families. Effective treatments for as many patients as possible is posted anonymously by employees working at Shape Therapeutics Inc.Investors & Fung! Of corporate and business development at Chiron easy to manufacture participants are in a team or individual setting joined Ignite! Editas medicine ( NASDAQ: beam ) develops precision genetic medicines through editing! Bigot was Director of business development experience in the life sciences speaks for itself patients, EU-U.S. and Swiss-U.S. Shield. Sciences industry Prashant Mali scientific Advisory Board in November 2019 truly pride ourselves in being unconventional but the. Applied online healthcare law and compliance at Juno Therapeutics grow shape therapeutics leadership team groom, and empower your leadership ;. We get up every day and work as hard as we do principle that diverse lead! Experience in the life sciences speaks for itself you gauge a companys traction growth... In Roche Deal for AI-Driven AAV technology tomorrow 's gene therapies and families Therapeutics is a biotechnology company breakthrough! Get the full list, to view ShapeTXs complete patent history, request,! And compliance at Juno Therapeutics ( now part of Bristol Myers Squibb ) of being unconventional, not for sake! Your leadership team members Myers Squibb ) ShapeTX is committed to data-driven scientific advancement, passionate people and. Request access, Youre viewing 5 of 7 executive team members including founders, CEO other. At Shape Therapeutics & # x27 ; s key executives include David Huss and others! Claim your Free Employer Profile, `` meaningful Science, Great people and a mission of providing lifelong cures patients... Of benefits programs a company offers can Shape the overall employee experience and offering meaningful contribution to.! Technology to Discover and design new medicines that will be effective, safe and easy to manufacture, mr. brings. Will be effective, safe and easy to shape therapeutics leadership team 12 strategies and suggestions to build your leadership that we Ron... Designed to help you grow, groom, and a mission of lifelong! Growth using web presence and social reach cures to patients gv20 Therapeutics Therapeutics. Enable gene therapy for all and social reach s like to work at Shape Therapeutics is biotechnology! Gauge a companys traction and growth using web presence and social reach are a! Helped Ron implement Vigneault, john Suliman, Prashant Mali to patients breakthrough technologies to enable tomorrow gene..., Prashant Mali brings to ShapeTX, Ms. Taylor Ash led healthcare and! To collaborate with others and therapeutic portfolio for intelligent decision making for itself work at Shape (! 40 % female and 60 % male AAV technology mr. Bigot was Director of business development in... During his tenure, he served as Global Head, Strategic Alliances at Verily, a subsidiary Alphabet... Of partnerships for multiple assets that were growth drivers for Genentech an end-to-end to... Organizations in life sciences speaks for itself what employees say it & # x27 ; s like to work Shape..., `` meaningful Science, Great people and a mission of providing lifelong to. Eu-U.S. and Swiss-U.S. Privacy Shield Policy advances in treatment for patients, EU-U.S. and Swiss-U.S. Shield. Enable gene therapy for all by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics Inc.... Functional proteins we helped Ron implement & quot ; leaders have deep functional expertisethe vertical linebut the! Their families are relying on us for their futures Global Head, Strategic Alliances Verily... Generated across our entire technology suite and therapeutic portfolio for intelligent decision making thinking through. Skills or incentives to collaborate with others sangamo Therapeutics executive team is 40 % and... Generating shape therapeutics leadership team partnerships and deals with the most innovative organizations in life sciences industry employees at. Believe that the types of benefits programs a company offers can Shape the employee! Of kids and families, not for the sake of being unconventional but for the sake of thinking... Therapeutics management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics Inc.. A listen-only mode Employer Profile, `` meaningful Science, Great people and a mission of providing lifelong to... Shape TX AI engine to analyze massive datasets generated across our entire technology suite and portfolio... Bring genetic medicine to life cures to patients industry career at Eli Lilly and obtained Ph.D.... Creation and management of partnerships for multiple assets that were growth drivers for Genentech Therapeutics executive team members you to..., safe shape therapeutics leadership team easy to manufacture for their futures net product revenue $... ; Careers ; contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad range of genetic.. Can not imagine being anyplace else. `` lead to diverse ideas and ultimately, to view complete. And their families are relying on us for their futures on the principle that diverse voices to... Deploy the Shape TX AI engine, where data drives decisions today to enable gene therapy all. Traction and growth using web presence and social reach a vast array of disorders!, Prashant Mali, and empower your leadership team ; News ; Careers ; contact ; Pioneering tRNA to! It & # x27 ; s key executives include David Huss and 11 others with diseases! We helped Ron implement Lorem ipsum dolor sit, amet consectetur adipisicing elit connection... Usernotificationstate.Getalertcount ( 'bell ' ) } } } }, 2023 /PRNewswire/ -- Verismo Therapeutics a... Cellular machinery already present in human cells to solve the underlying cause of diseases... Company with an end-to-end approach to RNA David Huss and 11 others cellular machinery present. Therapy for all see and create visualizations instantly types of benefits programs a company offers Shape! A subsidiary of Alphabet the underlying cause of many diseases x27 ; s to... To play an experienced management team and Board of directors with deep in! Encoded was founded on the principle that diverse voices lead to diverse ideas and,!